Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCOG ALL-9 childhood acute lymphoblastic leukemia protocol
NL-OMON21934Active, not recruiting
- Sponsor
- Dutch Childhood Oncology Group
- Start
- Jan 1997
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexamethasone in acute lymphoblastic leukemia (ALL) (2 cohorts), sponsored by Dutch Childhood Oncology Group. Primary endpoint: Overall survival. Started Jan 1997; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON21934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21934.